How Angeliki Fund is building a consolidated dementia-care platform — and finding family offices who share the long-hold thesis

A specialized fund for a fragmented market

Angeliki Fund is a specialized private-equity firm raising Fund I behind a single thesis: that the dementia-care market is large, fragmented, and structurally underserved, and that a consolidated operating platform built across four complementary service lines can deliver better outcomes for patients and families while compounding capital over a long hold. The firm describes itself, plainly, as specialized private equity in dementia-care services.

The public framing of the problem is direct. US dementia care is a $360 billion market characterized by uncoordinated services and poor outcomes for patients, projected to grow to $1 trillion by 2050 as the population ages. Angeliki calls it "the largest unmet market opportunity in healthcare" and argues the winners will not be single-service roll-ups but integrated platforms combining clinical care, technology, and wrap-around services.

A four-pillar operating platform

Angeliki Fund's platform is built around four dementia-care service pillars operated under a single company, with an AI and telehealth layer running across all of them. Memory Care provides residential and day-program care for patients with dementia and Alzheimer's. Apheresis Clinics deliver the regulated clinical services used in the treatment and management of dementia-related conditions. Hospice covers end-of-life care integrated with the rest of the patient journey. Estate Planning wraps around all of it, supporting families navigating late-life financial and legal decisions.

The firm's argument is that the four pillars reinforce one another in ways single-service operators cannot replicate. A family who enters through Memory Care is a natural candidate for Apheresis, Hospice, and Estate Planning as the patient's needs evolve. That produces predictable patient flow, higher lifetime value per family, lower acquisition costs from internal referrals, and real cross-sell across the lifecycle. Diversification across four revenue pillars and multiple payer sources is positioned as a materially lower risk profile than dementia-specific single-service roll-ups.

A bench built to scale healthcare platforms

Angeliki Fund's team combines capital-markets, clinical, governance, and multi-site operating experience. Nikiforos Panorios leads platform strategy and capital markets, driving acquisition strategy, integration roadmap, and capital structuring for multi-asset platforms. Michael Deem, PhD, handles clinical innovation and strategic transactions; he led the $2.3 billion exit of Ion Torrent and is the architect of global apheresis platform deals, bringing deep regulated-healthcare and technology-enabled-care expertise.

Ronald DaVella covers governance, M&A, and compliance infrastructure after a 34-year Deloitte partnership spanning IPO, M&A, SEC, and compliance work. Shaun Ginter is the operating partner on multi-site healthcare scaling; as former COO of Solantic he scaled that business from 11 to 37 clinics and is a past president of the Urgent Care Association.

Why family offices are the target LP

Angeliki Fund is explicit that family offices — not generic fund-of-funds or transactional institutional LPs — are the intended capital base. The pitch is structured around four alignments: control, with the fund acquiring and operating multi-site dementia operators as one company and GP capital at risk alongside families; capital preservation, with central compliance reducing regulatory risk, payer scale supporting stable margins, and standardized operations producing predictable cash flow; multi-generational value creation, with the model designed for long holds and compounding rather than short-term financial engineering; and direct partnership, with family partners investing alongside the fund in individual acquisitions and priority allocation for lead partners.

That profile — long-duration, concentration-tolerant, healthcare-literate, open to direct co-investment — is a narrower slice of the family-office universe than generic fundraising lists surface.

Angeliki Fund's research workflow with Altss

Angeliki's workflow treats LP discovery as a signal-intersection problem. A match for this thesis has to combine three behaviors at once: prior exposure to healthcare-services roll-ups, a documented pattern of direct co-investment alongside specialist GPs rather than pure fund commitments, and a multi-generational hold horizon that tolerates long-duration compounding over financial engineering.

Altss makes that three-way filter operable. The team narrows offices by healthcare-services history — aging-care, senior living, hospice, and clinical roll-ups — and overlays offices with a track record of writing checks directly into operator-led healthcare deals rather than committing only to GP funds. A further overlay surfaces multi-generational families whose stated mandates emphasize compounding over exit cycles.

What comes out the other side is a deliberately short list where every name has already proven all three behaviors. Verified decision-maker contacts route outreach to the principal or head of direct investments rather than a generic inbox, so first conversations open on strategy fit rather than on mass-market education.